Bu sayfanın çevirisi deneyseldir ve geliştirilme aşamasındadır. imlerinizi bekliyoruz!

Hang Lung Properties Bilanço Sağlığı

Finansal Sağlık kriter kontrolleri 3/6

Hang Lung Properties şirketinin toplam hissedar öz sermayesi HK$141.9B ve toplam borcu HK$53.8B olup, bu da borç-öz sermaye oranını 37.9% seviyesine getiriyor. Toplam varlıkları ve toplam yükümlülükleri sırasıyla HK$218.9B ve HK$77.0B dir. Hang Lung Properties 'in FAVÖK'ü HK$6.4B faiz karşılama oranı 9.1 dur. Şirketin HK$6.5B tutarında nakit ve kısa vadeli yatırımları bulunmaktadır.

Anahtar bilgiler

37.9%

Borç/özkaynak oranı

HK$53.83b

Borç

Faiz karşılama oranı	9.1x
Nakit	HK$6.46b
Eşitlik	HK$141.90b
Toplam yükümlülükler	HK$77.04b
Toplam varlıklar	HK$218.94b

Son finansal sağlık güncellemeleri

Güncelleme yok

Recent updates

Finansal Durum Analizi

Kısa Vadeli Yükümlülükler: 101 'nin kısa vadeli varlıkları ( HK$24.3B ) kısa vadeli yükümlülüklerini ( HK$16.0B ) aşıyor.

Uzun Vadeli Yükümlülükler: 101 'un kısa vadeli varlıkları ( HK$24.3B ) uzun vadeli yükümlülüklerini ( HK$61.0B ) karşılamamaktadır.

Borç-Özkaynak Tarihçesi ve Analizi

Borç Seviyesi: 101 'nin net borç/öz sermaye oranı ( 33.4% ) tatmin edici olarak değerlendirilmektedir.

Borcun Azaltılması: 101 şirketinin borç/öz sermaye oranı son 5 yılda 22.3% seviyesinden 37.9% seviyesine yükseldi.

Borç Kapsamı: 101 'nin borcu işletme nakit akışı ( 6.5% ) tarafından iyi bir şekilde karşılanmıyor.

Faiz Kapsamı: 101 'in borcuna ilişkin faiz ödemeleri EBIT ( 9.1 x kapsam) tarafından iyi bir şekilde karşılanmaktadır.

Hang Lung Properties Bilanço Sağlığı

Finansal Sağlık kriter kontrolleri 3/6

Anahtar bilgiler

Son finansal sağlık güncellemeleri

Recent updates

Now 25% overvalued after recent price rise

Investor sentiment improves as stock rises 16%

First half 2024 earnings released: EPS: HK$0.23 (vs HK$0.53 in 1H 2023)

Upcoming dividend of HK$0.12 per share

First half 2024 earnings released: EPS: HK$0.23 (vs HK$0.53 in 1H 2023)

New major risk - Dividend sustainability

Now 22% undervalued after recent price drop

Hang Lung Properties Limited to Report First Half, 2024 Results on Jul 30, 2024

Now 23% undervalued after recent price drop

Now 22% undervalued after recent price drop

New minor risk - Shareholder dilution

Hang Lung Properties Limited Announces Final Dividend for the Year Ended 31 December 2023, Payable on 14 June 2024

New minor risk - Dividend sustainability

Full year 2023 earnings released: EPS: HK$0.88 (vs HK$0.85 in FY 2022)

Hang Lung Properties Limited Announces Board Changes

Executive Vice Chair of the Board recently bought HK$1.8m worth of stock

Final dividend of HK$0.60 announced

Hang Lung Properties Limited, Annual General Meeting, Apr 26, 2024

Full year 2023 earnings released: EPS: HK$0.88 (vs HK$0.85 in FY 2022)

Hang Lung Properties Limited and Hang Lung Group Limited Announce Retirement of Mr. Ronnie Chichung Chan as the Chair, an Executive Director, and the Chair of Executive Committees, with Effect from April 26, 2024

Hang Lung Properties Limited, Annual General Meeting, Apr 26, 2024

Now 20% overvalued

Hang Lung Properties Limited to Report Fiscal Year 2023 Results on Jan 30, 2024

Hang Lung Properties Limited Declares Interim Dividend to Be Paid in Cash on September 29, 2023

Upcoming dividend of HK$0.18 per share at 7.4% yield

CEO & Executive Director recently bought HK$506k worth of stock

First half 2023 earnings released: EPS: HK$0.53 (vs HK$0.43 in 1H 2022)

Hang Lung Properties Limited Announces Interim Dividend for the Six Months Ended 30 June 2023

Hang Lung Properties Limited to Report First Half, 2023 Results on Jul 31, 2023

Upcoming dividend of HK$0.60 per share at 5.5% yield

Full year 2022 earnings released: EPS: HK$0.85 (vs HK$0.86 in FY 2021)

Full year 2022 earnings released: EPS: HK$0.85 (vs HK$0.86 in FY 2021)

Hang Lung Properties Limited Proposes Final Dividend for the Year Ended 31 December 2022, Payable on 19 May 2023

Hang Lung Properties Limited to Report Fiscal Year 2022 Results on Jan 31, 2023

Insufficient new directors

Investor sentiment deteriorated over the past week

Executive Vice Chair of the Board recently bought HK$5.0m worth of stock

Upcoming dividend of HK$0.18 per share

CEO & Executive Director recently bought HK$669k worth of stock

CEO & Executive Director recently bought HK$798k worth of stock

First half 2022 earnings released: EPS: HK$0.43 (vs HK$0.50 in 1H 2021)

Hang Lung Properties Limited Declares Interim Dividend for the Six Months Ended 30 June 2022, Payable on 29 September 2022

Hang Lung Properties Limited to Report First Half, 2022 Results on Jul 28, 2022

Hang Lung Properties Declares Final Dividend for 2021

Insufficient new directors

Full year 2021 earnings: EPS in line with expectations, revenues disappoint

Hang Lung Properties Limited Declares Final Dividend for the Year Ended 31 December 2021 Payable on 19 May 2022

CEO & Executive Director recently bought HK$822k worth of stock

First half 2021 earnings released: EPS HK$0.50 (vs HK$0.56 loss in 1H 2020)

CEO & Executive Director recently bought HK$4.5m worth of stock

Upcoming dividend of HK$0.18 per share

First half 2021 earnings released: EPS HK$0.50 (vs HK$0.56 loss in 1H 2020)

Director of General Counsel has left the company

Independent Non-Executive Director has left the company

Hang Lung Properties Limited Declares Final Dividend

Upcoming dividend of HK$0.59 per share

Full year 2020 earnings released: HK$0.57 loss per share (vs HK$1.37 profit in FY 2019)

New 90-day high: HK$22.30

Hang Lung Properties Limited Announces Retirement of Ronald Joseph Arculli as Independent Non-Executive Director

Full year 2020 earnings released: HK$0.57 loss per share (vs HK$1.37 profit in FY 2019)

Revenue misses expectations

Hang Lung Properties Limited, Annual General Meeting, Apr 30, 2021

Hang Lung Properties Limited to Report Fiscal Year 2020 Results on Jan 28, 2021

Hang Lung Collaborates with Hyatt to Open New Luxury Grand Hyatt Hotel in Kunming

First half earnings released

Upcoming Dividend of HK$0.17 Per Share

New 90-day high - HK$21.75

Finansal Durum Analizi

Borç-Özkaynak Tarihçesi ve Analizi

Bilanço

Sağlıklı şirketleri keşfedin